Regnite to treat primary restless legs syndrome launched in Japan – News-Medical.net

by admin on August 2, 2012

Regnite to treat primary restless legs syndrome launched in Japan
News-Medical.net
Astellas Pharma Inc. (Tokyo: 4503) and XenoPort, Inc. (NASDAQ: XNPT) announced today that Regnite® (gabapentin enacarbil) Extended-Release Tablets will be launched in Japan on July 10, 2012. Regnite is approved in Japan for the treatment of
Astellas and XenoPort Announce the Launch of Regnite(R) Tablets for Restless MarketWatch (press release)

all 9 news articles »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: